Watch Ticker

Medpace Holdings, Inc. Common Stock

Go to Medpace Holdings, Inc. Common Stock Website

$432.43

9.34 (2.21%)

Live

Previous Close

$423.09

Day Range

$420.47 - $432.43

Previous Day Range

$412.35 - $425.875

Market Cap

$11.9 billion USD

Day Vol.

293950

Previous Day Vol.

517836

Currency

USD

Primary Exchange

Nasdaq

Medpace is a late-stage contract research organization that provides full-service drug-development and clinical trial services to small and midsize biotechnology, pharmaceutical, and medical device firms. It also offers ancillary services, including ...

Community

0 posts discussing

0

Watchers

0

Visitors

Recent News

Jesterai - Medpace Beats Q2 Revenue Estimates

Medpace, a clinical contract research organization, reported strong Q2 2025 earnings, exceeding analyst expectations with 14.2% revenue growth and raised full-year guidance despite sector challenges.

Related tickers: MEDP.

Read Full Article

Towards Healthcare - Preclinical CRO Market Size at USD 6.8 Billion in 2025, Forecasted to Grow at 8.73% CAGR Through 2034

The global preclinical Contract Research Organization (CRO) market is projected to grow from USD 6.8 billion in 2025 to USD 14.34 billion by 2034, driven by increased pharmaceutical R&D, technological advancements, and demand for specialized research services.

Related tickers: WUXAY, CRL, TMO, MEDP.

Read Full Article

Trending Tickers

Please sign in to view